Skip to main content

colorectal cancer Archives

Gene profile predicts metastasis

Feb. 9, 2015—A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.

Read more


Study in East Asians identifies genes tied to colon cancer risk

Aug. 21, 2014—Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.

Read more


Colon cancer’s protein signatures identified

Jul. 24, 2014—A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.

Read more


Tumor factor spurs blood vessel growth

Aug. 26, 2013—A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

Read more


$5.2M NIH grant bolsters colorectal cancer research

Aug. 15, 2013—Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

Read more


Vanderbilt, GE unite to study colon tumor development

Jan. 31, 2013—Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

Read more


Three new genetic links to colorectal cancer revealed

Jan. 10, 2013—Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.

Read more


Green tea found to reduce rate of some GI cancers

Oct. 31, 2012—Green tea may lower risk of some digestive cancers.

Read more


An orphan enzyme’s purpose

Oct. 4, 2012—“Orphan” enzyme may play role in cancer growth, new research suggests.

Read more


Grant renewal boosts GI cancer research program

Sep. 20, 2012—Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI).

Read more


Colon cancer’s cellular crossroads

Mar. 16, 2012—New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

Read more


Urine biomarker for colon cancer?

Mar. 10, 2012—A molecule detectable in urine may be helpful in diagnosing colon cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more